CervoMed stockholders elect seven directors and approve 2025 equity plan at annual meeting

CervoMed Inc.

All seven director nominees elected; John Alam received 3,923,241 votes for, 21,554 withheld.
Ratification of RSM US LLP as auditor approved: 5,571,505 for, 25,008 against, 13,724 abstain.
Advisory vote on 2024 executive compensation approved with 3,891,229 for, 33,195 against, 20,371 abstain.
CervoMed 2025 Equity Incentive Plan approved: 3,798,568 for, 137,758 against, 8,469 abstain.
Approximately 5.61 million shares voted, representing 64.5% of outstanding shares; all proposals passed.

item 5.07item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.